Economy

Growth Cut in Half, Margins Guided Lower — and the Stock Jumped 35%?

AI Generated Image - An editorial illustration of an hourglass on an office desk where multiple figures actively pull sand upward from the lower chamber into the already-full upper chamber, representing accelerated resource transfer
AI Generated Image - An editorial digital illustration depicting asymmetric resource transfer through an hourglass metaphor, representing the acceleration of future assets into the present

Summary

Atlassian's (TEAM) Q4 FY2026 results delivered revenue of $1.77 billion (+28% YoY) and non-GAAP EPS of $1.87, significantly beating market expectations and sending the stock up roughly 35% in a single session. Yet the same earnings report simultaneously guided FY2027 total revenue growth at approximately +13% — exactly half of FY2026's +26% — a deceleration that deserves far more scrutiny than the market's initial reaction suggested. Non-GAAP operating margin guidance was also stepped down from FY2026's actual 30% to 25.0% for FY2027, a 5-percentage-point reduction in the very profitability metric the market was celebrating as a margin-driven re-rating story. FY2026's 26% growth was itself partly the product of accelerated Data Center contract revenue recognition tied to the pending March 2029 product sunset, a dynamic the company openly acknowledged in its shareholder letter as a pull-forward of customer purchasing from future periods that significantly benefited FY26 Data Center revenue. In a year when revenue grew 26%, free cash flow actually declined 6.8%, accounts receivable surged 63.2%, and the company recorded an annual GAAP net loss of $53.8 million — numbers that tell a meaningfully different story than the headline figures. This analysis digs into the SEC filings directly to examine what the market read as a triumph and what the guidance actually implies for FY2027 and beyond.

Key Points

1

Growth Halved, Stock Up 35% — The SaaS Valuation Paradigm Is Shifting

Atlassian guided FY2027 total revenue growth at approximately +13% — exactly half of FY2026's +26% — and on the same day the market sent the stock up roughly 35%, which tells you something important about how the framework for pricing SaaS equities has changed. Between 2023 and 2026, the market moved away from "growth rate times multiple" toward Rule of 40 — the sum of growth rate and profitability margin — as the primary lens for SaaS valuation. FY2026's Rule of 40 for Atlassian was 26 plus 30, equaling 56, a number that commands a premium, and the market rewarded it accordingly. But plugging in FY2027 guidance yields 13 plus 25, equaling 38, which falls below the 40 threshold that the software industry uses as a rough performance benchmark. Whether the market treats that dip as a temporary trough on the path to FY2028 re-acceleration, or as a structural inflection point in the SaaS growth story more broadly, will define the stock's trajectory over the next four to eight quarters. The "slowing growth is fine as long as margins hold" thesis got its first major empirical test in this earnings report — and the immediate problem is that margins didn't hold either, with FY2027 non-GAAP operating margin guided 5 points lower than FY2026 actual. I think the market is pricing a scenario where FY2027 is a transient dip; whether the underlying business confirms that optimism or disproves it will determine whether this roughly 35% gain was prescient or premature.

2

FY2026's 26% Growth Was Borrowed — The Data Center Pull-Forward Mechanics

The central accounting fact that makes this earnings report complicated is that FY2026's 26% growth was not purely organic, and the company said so directly. Atlassian announced the March 2029 Data Center end-of-life in September 2025, and customers responded predictably by accelerating long-term DC contract signings to lock in terms before the sunset date. Under ASC 606, "term license" contracts can be recognized upfront at inception, so the revenue from multi-year agreements flooded into FY2026 in a concentrated burst rather than spreading across contract terms. The company acknowledged this without ambiguity in the shareholder letter: "pull-forward of customer purchasing from future periods that significantly benefited FY26 Data Center revenue." This wasn't a Q4 surprise — the CFO had already flagged roughly $50 million in excess upfront term license revenue recognition the prior quarter and described the dynamic as "lumpiness," so the company confirmed the same phenomenon two consecutive quarters. FY2026 Data Center revenue grew +24.8% partly on borrowed future revenue, and FY2027 pays back that borrowing as approximately -17% decline. Investors who read +26% as pure organic demand acceleration will experience +13% as a shock; investors who understand the pull-forward mechanics will recognize it as the mathematically inevitable other side of the same coin, fully disclosed in the filing.

3

The $6.06 Per-Share GAAP-to-Non-GAAP Gap — SBC and the Architecture of the Margin

FY2026 non-GAAP EPS of $5.85 against GAAP EPS of $(0.21) represents a $6.06 per-share difference, and virtually all of it originates in $1.61 billion of stock-based compensation — equal to 24.4% of FY2026 revenue. Full-year GAAP operating income was just $10.355 million, making SBC roughly 155 times GAAP operating income — a ratio that borders on structurally incoherent. The non-GAAP operating margin of 30% is mechanically real, but it reflects a business where nearly one quarter of revenues are distributed to employees in equity rather than cash. In peer context: Salesforce's FY2025 SBC was 8.4% of revenue, ServiceNow 14.7%, Datadog 22.6% — Atlassian sits at the top of that peer group. FY2027 guidance brings SBC down to approximately 19%, but at 19% the company is still paying out nearly one-fifth of revenue in stock. GAAP operating margin is guided to improve from effectively 0% to approximately 4.5% — directionally meaningful, but leaving a roughly 20-point gap to the non-GAAP figure that takes years to close. Until it does, the question "is this company actually profitable?" will follow every quarterly report. The FY2026 annual GAAP net loss of $53.8 million is the honest headline that deserves to sit alongside every non-GAAP margin discussion.

4

FY2027 Margins Are Also Guided Lower — The Sharpest Number the Market Underweighted

The market received Atlassian's Q4 FY2026 results as a "margin story," and the Q4 non-GAAP operating margin of 36% became the evidence cited in much of the commentary. What received comparatively less attention: FY2027 non-GAAP operating margin is guided at 25.0% — 5 percentage points below FY2026's actual 30%. Q4's 36% was a quarterly high-water mark driven by seasonal revenue concentration in Q4, not a new sustained baseline. If this is a margin story, the margins need to be improving — and FY2027's guidance says they are not, at least on a non-GAAP basis. The company flagged aggressive Cloud infrastructure investment and continued AI R&D spending, both of which will load into the cost base. R&D was already running at approximately 50% of revenue in FY2026, and if that ratio holds or rises in FY2027, the non-GAAP margin trajectory stays under pressure. SBC reduction will improve the GAAP picture, but the market awarded its premium to non-GAAP numbers — and those are the numbers going lower in FY2027. On FY2027 guidance, the Rule of 40 score falls from 56 to 38, dipping below the common benchmark threshold at the very moment the market was celebrating Atlassian's Rule of 40 strength. I consider this 5-point guidance step-down the single most important number that the market underweighted on earnings day.

5

Free Cash Flow Down 6.8% While Revenue Grew 26% — The Cash Quality Question

In any year where revenue grows 26%, free cash flow declining 6.8% is unusual enough to command sustained scrutiny — and this divergence has a specific structural explanation that matters for the outlook. Atlassian's FY2026 FCF was $1.32 billion, down from $1.42 billion the prior year, while accounts receivable surged from $778 million to $1.27 billion, a 63.2% increase against revenue growth of 26%. Receivables growing at 2.4 times the rate of revenue is a direct consequence of upfront term license recognition with payment installments spread across the contract term — the cash has not yet arrived from revenue already counted. The change in accounts receivable on the cash flow statement swung from -$150 million in FY2025 to -$484 million in FY2026, a more-than-threefold deterioration. Cash and securities fell from $2.94 billion to $1.24 billion, driven by $1.8 billion in buybacks and $1.23 billion in acquisitions. Stockholders' equity declined 21.3% even as SBC contributed $1.61 billion in equity, because buyback outflows more than absorbed those additions. With $1.24 billion remaining and long-term debt of $990 million, the financial cushion for future large-scale M&A or accelerated investment is meaningfully thinner than twelve months ago, and I consider accounts receivable days outstanding the most reliable near-term indicator of whether FY2026's growth was as real as the income statement suggested.

Positive & Negative Analysis

Positive Aspects

  • RPO +44% Confirms a Deep and Expanding Contract Pipeline

    The demand indicator I find most compelling in Atlassian's results is RPO of $4.82 billion, up 44% — growing nearly twice as fast as ARR at +23%. When RPO growth significantly outpaces ARR growth, it signals customers are committing to longer contract terms and larger deal sizes, which is structurally exactly what you want to see in an enterprise software company facing a product transition. The $5M+ ARR customer cohort grew 70%; the $3M+ cohort grew 50%; and the company closed what it described as its largest enterprise deal in company history with a major unnamed global consumer technology firm. Large contracts backlog into RPO before they convert to recognized revenue, which means RPO at +44% represents a contractually committed pipeline of future revenue, not merely anticipated demand. The elongation of average contract duration also improves revenue visibility across multiple quarters, providing a structural positive that is entirely independent of the pull-forward accounting controversy. Even if FY2027 delivers the Data Center headwind the company guided, this RPO backlog provides a meaningful buffer and argues that enterprise demand for Atlassian's platform is durable and deepening, not deteriorating. Pipeline quality of this type is not something that can be manufactured through timing adjustments.

  • Cloud Revenue Accelerating at 31% With Durable Structural Tailwinds Behind It

    Q4 Cloud revenue of $1.21 billion grew 31% year over year — accelerating from prior-quarter trends — and Cloud represented 67% of FY2026 total revenue, a share that will expand toward 75 to 80% as Data Center approaches its March 2029 sunset. The Cloud model's fundamental appeal is the combination of predictable recurring revenue and expanding unit economics at scale. Subscription ARR at $6.61 billion, up 23%, reflects a business model that compounds annually rather than requiring constant new sales cycles. With over 350,000 customers already on the platform, the installed base creates a natural expansion motion as organizations grow their seat counts and adopt premium modules like Rovo. The transition from Data Center to Cloud also tends to produce higher ARPC in many customer segments, because Cloud pricing bundles capabilities that were optional or separately licensed in DC deployments. As Cloud approaches 75 to 80% of total revenue, the gross margin profile — currently approximately 85% — has room to expand further by eliminating the hardware and dedicated support overhead that the Data Center model required. I think the moment Cloud exceeds 80% of total revenue is a genuine valuation inflection point, because at that stage the business becomes straightforwardly comparable to pure-play Cloud SaaS peers on any metric.

  • Rovo and MCP Are Generating Real Adoption Data, Not Just Announcements

    What distinguishes Atlassian's AI positioning from most enterprise software AI narratives is the presence of actual adoption metrics that can be independently examined, not just roadmap promises. Over 80% of the Fortune 500 is already using Rovo; customers with Rovo active show 20% more Jira task volume and 25% more Confluence page creation versus non-Rovo users, with ARR growth rates more than double those of non-Rovo customers. MCP server and Teamwork Graph CLI monthly active users more than doubled in a single quarter, crossing one million, while MCP call volume surged over 400%. Atlassian's 25 years of enterprise workflow data and the Teamwork Graph — with over 200 billion objects and connections — are becoming the underlying data layer that external AI agents query to do real work. Graph-based agents show 44% better answer accuracy and 48% lower token consumption compared to alternative approaches, which is the kind of measurable differentiation that drives adoption decisions in enterprise IT. In a world where AI agent effectiveness depends heavily on data quality and relationship structure — not just raw data volume — Atlassian's position as the repository of enterprise work knowledge accumulated over 25 years is a competitive asset that cannot be replicated quickly by well-resourced incumbents, let alone new entrants.

  • First Quarterly GAAP Profit and a Clear SBC Reduction Path Forward

    Atlassian's Q4 FY2026 GAAP net income of $139 million and GAAP operating margin of 12% marked the first quarterly GAAP profit in the company's history — an important milestone even if the full-year picture still shows an annual net loss of $53.8 million. The directional signal matters beyond the single quarter, because it demonstrates that the business model can produce GAAP profitability when seasonal revenue concentration aligns favorably, and it establishes a baseline from which to measure progress. More structurally meaningful is the announced SBC trajectory: from 24.4% of revenue in FY2026 to approximately 19% in FY2027 guidance, which the company expects to drive GAAP operating margin improvement from effectively 0% to approximately 4.5%. If that trajectory holds and continues at a similar pace, FY2028 or FY2029 could see GAAP operating margins cross into double digits for the first time on a full-year basis. The market tends to re-rate companies as they transition into sustained GAAP profitability, because there is a meaningful segment of institutional capital that cannot or will not hold GAAP-negative businesses regardless of non-GAAP metrics. Atlassian's expansion into that investor pool — as GAAP profitability becomes consistent rather than exceptional — represents an independent valuation support mechanism that is entirely separate from the revenue growth trajectory.

  • Cannon-Brookes' Intention to Enter a $250 Million Personal Trading Plan

    CEO Mike Cannon-Brookes announced his intention to enter into a 10b5-1 plan to purchase up to $250 million of Atlassian stock, effective after market close on August 7, 2026. While the 8-K specifically states that he "announced his intention to enter into a trading plan" — meaning this is an intention subject to a mandatory cooling-off period, not an executed purchase — the public signal from a founder-CEO who built the company from the ground up carries meaningful information about his assessment of current price relative to intrinsic value. When insiders of that profile announce purchasing plans of that magnitude, the implied message to the market is that they believe the stock represents an undervaluation — a signal that is more credible coming from the founder than from any external party. The company-level buyback program also executed $1.8 billion in FY2026 repurchases, including $359 million in Q4 alone, providing a second independent data point of capital allocation behavior by those with the most complete information. Actual Form 4 disclosures will be the confirmation mechanism — when and if purchase transactions are reported after the cooling-off period, the intention transforms into executed conviction, and that distinction matters significantly in assessing the strength of the insider signal.

Concerns

  • Data Center -17% Will Hit Harder in H2 FY2027 Than the Annual Average Implies

    The approximately -17% annual Data Center decline for FY2027 is a headline number, but the quarterly distribution of that decline is likely to be substantially uneven — and that distributional reality matters for how each quarterly earnings release will be received by the market. Pull-forward activity concentrated in H2 FY2026, which means H2 FY2027 comparisons face the most elevated base period. The full-year -17% average could mask H2 FY2027 quarterly Data Center declines that are materially worse than that figure, creating a sequence of earnings reports where "Data Center worse than annual guidance implied" becomes a recurring market narrative even if the full-year result tracks the guidance. Cloud at +25.5% would need to fully absorb each quarter's DC deterioration to sustain +13% total growth — and if Cloud's growth rate fluctuates even modestly in any given quarter, the arithmetic can slip below that threshold quickly and create a headline miss dynamic. The company has guided FY2028 re-acceleration, but that re-acceleration is not guaranteed if Cloud growth decelerates before Data Center base effects fully expire. The near-certainty of the -17% headwind in FY2027 is paired with non-trivial uncertainty about the FY2028 recovery, and that asymmetry is worth pricing carefully into any medium-term valuation framework.

  • Accounts Receivable +63.2% and Cash -57.8% — Two Simultaneous Financial Warning Signals

    Accounts receivable growing at 63.2% while revenue grew 26% is not a routine data point — it is a direct signal that cash collection is lagging the revenue the income statement is booking, and the divergence between growth rates of that magnitude warrants sustained scrutiny across multiple quarters. The $1.27 billion year-end accounts receivable balance against $6.57 billion in annual revenue implies collection dynamics that will take multiple quarters to normalize under any optimistic scenario. The cash flow statement reinforces the concern: the accounts receivable use of cash swung from -$150 million in FY2025 to -$484 million in FY2026, a more-than-threefold deterioration in a single year. Simultaneously, cash and securities fell from $2.94 billion to $1.24 billion — a 57.8% decline — driven by $1.8 billion in buybacks and $1.23 billion in acquisitions. The effect is that Atlassian enters FY2027 with a substantially thinner liquidity buffer than it had entering FY2026, even as FCF declined and management has committed to continued investment spending. Stockholders' equity declined 21.3% despite $1.61 billion of SBC equity accretion, because buyback outflows consumed more than those additions. If receivable collection continues to lag in FY2027, or if any portion proves uncollectable, the FCF pressure extends beyond a single-year anomaly into a genuine structural concern about the underlying quality of FY2026's recognized revenue.

  • SBC at 24.4% of Revenue — A Structural Profitability Constraint Across the Peer Group

    Atlassian's $1.61 billion in stock-based compensation equals 24.4% of FY2026 revenue, placing it at the high end of the enterprise SaaS peer group: Salesforce at 8.4%, ServiceNow at 14.7%, Datadog at 22.6%. The non-GAAP operating margin of 30% is mechanically real, but it reflects a compensation model where nearly one quarter of revenue is distributed to employees in equity rather than cash — meaning the non-GAAP profitability is in large part a function of compensation accounting choices rather than operational cash efficiency. Reducing SBC from 24.4% to 19% of revenue as FY2027 guidance implies requires restructuring how the company compensates its workforce, which is a genuinely difficult management challenge in the current AI talent market where top engineers and product leaders command exceptional total compensation packages. If key technical leaders depart as SBC is compressed, the AI and Cloud product investment thesis could be undermined at exactly the moment it needs to execute on the Rovo and MCP roadmaps. FY2026 also included $280 million in restructuring charges and $80.3 million in lease-related impairments, suggesting the cost structure is still being actively optimized rather than operating from a stable and durable baseline. The GAAP EPS of $(0.21) versus non-GAAP EPS of $5.85 is a $6.06 gap that will close slowly even under the most optimistic SBC reduction trajectory, and every quarterly report will be accompanied by the question of whether the GAAP picture is improving fast enough.

  • Non-GAAP Margin Guided to 25% — The "Margin Story" Was Already Stale on Earnings Day

    The market's reading of this earnings release as a "margin story" deserves direct challenge. Q4 FY2026 non-GAAP operating margin of 36% was a quarterly high-water mark driven by seasonal revenue concentration in Q4 — where a disproportionate share of annual enterprise deals close, mechanically elevating quarterly margins — and it is not a forward-looking run rate by any reasonable interpretation. The company's FY2027 annual non-GAAP operating margin guidance of 25.0% represents a 5-percentage-point decline from FY2026's actual 30%, meaning the "margins are improving" narrative is explicitly invalidated by the company's own guidance for at least the next full fiscal year. R&D at approximately 50% of revenue in FY2026 — and likely to remain near that level or higher as AI investment accelerates per management's stated intentions — creates a persistent cost pressure that the SBC reduction only partially offsets in non-GAAP terms. Sales and marketing growing 35.8% year over year to $1.54 billion reflects the ongoing cost of enterprise customer acquisition at a scale that won't compress materially in FY2027. On FY2027 guidance, the Rule of 40 score falls from 56 to 38, dipping below the commonly cited 40 benchmark at the very moment the market was celebrating Atlassian's Rule of 40 strength as the primary investment thesis. A market that cheered "margin expansion" in a report that guided margins lower may find FY2027's actual non-GAAP results a sobering contrast to the narrative it constructed on earnings day.

  • AI Data Openness Could Become a Structural Vulnerability Rather Than a Competitive Moat

    Atlassian's MCP server strategy — enabling external AI agents including Claude, ChatGPT, and Cursor to query Jira and Confluence data directly — is a compelling growth narrative with an equally compelling structural risk embedded inside it. If a growing share of MCP calls are write operations — meaning users are executing work tasks through external AI interfaces without ever opening Atlassian's native UI — then user time and relationship are migrating outward to those external agents even as the underlying data remains inside Atlassian's platform. Taken to its logical conclusion, this architecture could produce a company that owns the most important enterprise knowledge graph on the planet but captures a shrinking share of the value that knowledge creates, because the agents doing the work and building the user relationship sit at other companies. Atlassian's 25 years of enterprise workflow data is its deepest competitive moat; the open MCP strategy is designed to extend that moat into the AI era by making Atlassian the indispensable data layer every AI agent depends on. But a moat that works by making itself openly accessible to external platforms is structurally different from a moat built on exclusivity or switching costs. Whether "indispensable data layer" becomes a monetizable position that generates durable pricing power, or simply a cost center providing free infrastructure to external AI platforms that capture the lion's share of value, is a genuinely open question whose answer will not be clear for several years.

Outlook

To map what comes next, start with what the company actually guided. FY2027 total revenue growth approximately +13%, Cloud approximately +25.5%, Data Center approximately -17%, Marketplace and other approximately +12%, subscription ARR growth approximately +18%, non-GAAP operating margin approximately 25.0%, GAAP operating margin approximately 4.5%, SBC approximately 19% of revenue. For Q1 FY27: revenue $1.705 billion to $1.715 billion, non-GAAP operating margin approximately 28.5%, GAAP operating margin approximately 6.5%, GAAP gross margin 85.0%. These numbers are the canvas for the next twelve months. The central interpretive question is whether to read them at face value or through the lens of pull-forward mechanics and base effects. The answer is clearly the latter, and working through both lenses — near-term, medium-term, and long-term — is the only way to get an honest picture.

In the near term — call it the next six months — Q1 FY27 is the first real test. The revenue guidance midpoint of roughly $1.71 billion already exceeds market expectations of roughly $1.67 billion, so a headline beat is plausible and the setup looks manageable. But this is the quarter where Data Center base effects begin working against the comparisons in earnest. Q1 FY2026 still had relatively normal DC revenue before the pull-forward concentrated in the back half of the year, so the H1 FY2027 Data Center headwind may be more moderate than H2. Q1 non-GAAP operating margin guidance of 28.5% sits notably above the full-year guidance of 25.0%, reflecting standard SaaS seasonality where investment concentrates in the second half. I think Q1 is likely manageable — but the real tests arrive in Q2 and Q3, when base effects intensify.

Something else worth unpacking in the Q1 guidance: GAAP operating margin is guided at 6.5% versus the full-year 4.5%. The implication is that GAAP margins are most favorable in Q1 and will compress as AI investment and headcount expansion costs load into the back half of the year. When Q1 results land, the market may be tempted to extrapolate that 6.5% GAAP margin upward toward a higher annual trajectory. I think that extrapolation is dangerous. FY2026 saw Q4 non-GAAP operating margin at 36% versus the full-year 30%, and that Q4 peak was a product of seasonal revenue concentration — not a sustainable baseline. Confusing quarterly peaks with annual run rates is exactly the mistake the market already made reading the FY2026 results. Repeating it with FY2027 Q1 data would be a second iteration of the same error.

As FY2027 unfolds into its second half, the Data Center base effects will intensify significantly. Pull-forward activity concentrated in H2 FY2026, which means H2 FY2027 comparisons face the most elevated base. The full-year -17% annual average is almost certainly not uniformly distributed across quarters — H2 FY2027 quarterly Data Center declines could run materially worse than the annual average. Cloud at +25.5% would need to fully absorb each quarter's DC deterioration to sustain +13% total growth. At that stage, the market will likely frame each quarterly report as "Cloud acceleration versus Data Center drag." I think that framing is incomplete. What matters most is whether RPO growth — currently at +44% — sustains that trajectory, or whether the unwinding of pull-forward effects eventually surfaces there too.

The non-GAAP margin compression from 30% to 25% has near-term implications worth unpacking carefully. The company plans to reduce SBC from 24.4% to approximately 19% of revenue, which genuinely improves the GAAP picture — operating margin moving from effectively 0% to approximately 4.5% is directionally meaningful progress. But if SBC falls while total non-GAAP margins also fall, it means other costs are rising to absorb those savings. Atlassian has signaled aggressive investment in AI and Cloud infrastructure going forward. R&D was already approximately 50% of revenue in FY2026, and if that ratio holds or climbs in FY2027, the non-GAAP margin compression becomes self-reinforcing. I think the investment direction is strategically correct over a multi-year horizon, but the near-term tension between the "margin improvement" narrative and the 25% guidance will be difficult to avoid every quarter.

One more near-term variable that deserves attention: the competitive environment is evolving fast. Direct competitors like Monday.com and Asana are accelerating AI feature development, while adjacent players like ServiceNow and Microsoft Teams with Copilot integration are embedding AI capabilities aggressively across enterprise workflows. Atlassian's MCP and Rovo represent genuine differentiation, but the playing field has gotten more crowded. The DC-to-Cloud migration also creates a natural evaluation window — some customers may ask whether they want to migrate to Atlassian Cloud or take the opportunity to evaluate a competing platform entirely. This risk doesn't appear cleanly in guidance, but it will surface eventually in net dollar retention, which I would watch closely every single quarter going forward.

The accounts receivable trajectory — $1.27 billion at year-end, up 63.2% — is another near-term item deserving quarterly attention. The build in receivables likely reflects long-term contract revenue recognized upfront but not yet collected in cash. If Q1 and Q2 FY2027 see that balance normalize, free cash flow should rebound. If collection continues to lag, FCF could remain under pressure for two or more additional quarters, constraining the financial capacity for further investment or M&A at a time when cash reserves have already fallen sharply. I believe the accounts receivable days outstanding trend will be the most honest near-term barometer of this company's underlying cash quality — more revealing than any single margin metric.

In the medium term, there is a FY2028 hint embedded explicitly in the shareholder letter. The exact language: "we expect total revenue growth to re-accelerate in FY28 as we lap these effects." The logic is straightforward: FY2027 creates a low Data Center base, so FY2028 comparisons start from a depressed floor. As Data Center shrinks toward zero, its drag on aggregate growth diminishes proportionally. If Cloud was 67% of total revenue in FY2026, and Data Center shrinks at -17% while Cloud grows at +25%, Cloud could approach 75% of total revenue by FY2028 — at which point Data Center becomes too small to materially move the aggregate number in either direction.

The re-acceleration thesis carries important conditions, however. It requires Cloud growth at +25.5% or better to be sustained through FY2027 and into FY2028. FY2026 Cloud actually grew 27.9%, so the +25.5% FY2027 guide already represents a modest deceleration — which could be a one-time adjustment or the start of a structural trend. Cloud growth has two distinct engines: DC-to-Cloud migration, and new customer acquisition plus seat expansion from existing Cloud customers. When the DC-to-Cloud migration is largely complete — likely by FY2028 to FY2029 — one of those engines turns off. Whether pure organic Cloud growth alone can hold above 20% at that point is the medium-term linchpin question, and I'm honestly not certain the answer is yes without significant new revenue drivers from AI monetization.

SBC normalization also belongs in the medium-term discussion. From 24.4% in FY2026 to 19% in FY2027 guidance — if that trajectory continues at approximately 3 to 4 percentage points per year, SBC could reach the 15 to 17% range by FY2028 or FY2029. At that level, GAAP operating margins could cross into double digits, and the GAAP-to-non-GAAP gap closes in a genuinely meaningful way. I think this is the company's real re-rating catalyst. The market today awards a premium to non-GAAP numbers. Once GAAP margins reach double digits sustainably, the narrative shifts to "this company is profitable on any reasonable accounting basis" — which unlocks a different category of institutional capital allocation. The catch is that reducing SBC means restructuring how talent is compensated, and in the current AI talent market, lowering equity grant levels while retaining top engineers is a genuinely difficult balancing act.

Free cash flow normalization is equally important in the medium-term frame. The FY2026 FCF decline of 6.8% despite 26% revenue growth reflects the accounts receivable buildup from accelerated contract recognition. Those contracts will collect cash over their payment schedules, so if collections normalize in FY2027, FCF should recover. But if collections lag or impairments emerge, FCF pressure could persist well beyond a single-year anomaly. The company's decision to deploy $1.8 billion on buybacks and $1.23 billion on acquisitions in FY2026 leaves a thinner runway for opportunistic investment in FY2027. The $998 million in goodwill from FY2026 acquisitions also carries impairment risk if acquired assets underperform synergy expectations — a risk that is not remote given how quickly the AI landscape is shifting.

The durability of the buyback program also deserves scrutiny in the medium-term frame. FY2026's $1.8 billion repurchase was aggressive capital deployment. Whether FY2027 can sustain similar magnitudes depends directly on FCF recovery. If FCF doesn't rebound, buyback scale may have to shrink, which would itself be read as a negative signal by a market that has been rewarding the program as a sign of financial confidence. Conversely, if FCF normalizes while buybacks continue, it adds an additional layer of support to EPS growth. Watching whether Cannon-Brookes' personal 10b5-1 plan executes via Form 4 disclosures — and whether the corporate repurchase program continues at meaningful scale in FY2027 — will tell a lot about what the company's internal models imply about forward cash generation.

Looking out to the long term — past the March 2029 Data Center complete shutdown — Atlassian becomes a pure Cloud company. At that point, the pull-forward complexity, the base effects, and the DC-Cloud mix calculations all disappear. Cloud ARR growth rate simply becomes the company's growth rate, full stop. In this structure, gross margins have room to expand above the current approximately 85%. Data Center required hardware maintenance and dedicated support infrastructure that Cloud's scale economics eliminate. Against the company's cited $140 billion TAM growing at 14% annually, FY2026 revenue below 5% of that market argues for meaningful penetration runway remaining — with the caveat that I apply a standard discount to company-supplied TAM figures.

The largest long-term variable, though, isn't competition or TAM — it's whether AI strengthens or cannibalizes Atlassian's business model at a structural level. Current data leans positive. Rovo adoption correlating with 2x+ ARR growth rates means AI is genuinely enhancing product stickiness, not just adding a marketing layer. MCP crossing one million MAU means Atlassian data is becoming embedded in AI agent workflows at scale. The 200+ billion objects in the Teamwork Graph are an asset competitors cannot replicate quickly. But the same openness is a double-edged structural question. If a growing share of MCP calls are write operations — meaning users are executing work tasks through external AI interfaces without opening Atlassian's own UI — then user time and relationship is migrating outward even as the underlying data stays inside Atlassian. The company holds the data; the user interaction migrates to the agent.

The pricing model evolution adds another long-term dimension. Traditional seat-based billing may be giving way to usage-based or task-based models as AI agents replace human operators at certain workflows. Atlassian's emphasis on MCP call volume and agent metrics could be read as a prelude to metered pricing based on agent query volume or task execution. If Atlassian can monetize AI agent data access directly, that represents a new revenue layer above per-seat pricing that could materially expand ARPU without requiring additional seats. If the transition fails and AI erodes seat demand without a replacement model, the structural exposure is significant. The resolution of that pricing model question is probably the most important structural variable for Atlassian's post-FY2029 business trajectory.

The optimistic scenario looks like this. Cloud growth holds at 25% or better while Data Center base effects fade, enabling a genuine FY2028 re-acceleration to the 18 to 20% range. SBC falls approximately 3 to 4 percentage points annually, bringing GAAP operating margins above 10% before the end of the decade. Rovo and MCP monetization mature into measurable incremental revenue streams, pushing Cloud ARPC upward. RPO's +44% backlog converts into recognized revenue over two to three years, sustaining growth visibility through the DC transition. Accounts receivable normalizes and FCF rebounds to outpace revenue growth. The $5M+ customer cohort continues expanding at elevated rates, driving ARPC higher across the enterprise tier. In this scenario, "the pull-forward was transient noise and the structural growth was real" becomes the verdict in hindsight.

The pessimistic scenario is equally credible and should not be dismissed. Cloud growth slows below 25%, making it impossible to absorb DC's -17% drag while keeping total growth at +13%. Sector-wide AI automation erodes seat demand more broadly, compressing net dollar retention across the SaaS industry. Some DC customers defect to competing platforms during the migration window rather than moving to Atlassian Cloud. SBC reduction triggers talent attrition in an environment where AI engineers command extraordinary compensation. Accounts receivable collection continues to lag for a second consecutive year, further pressuring cash at a time when the reserve is already thin. In this scenario, "Atlassian survived the SaaSpocalypse" gives way to "SaaSpocalypse was postponed, not averted" — a narrative that was sitting just beneath the surface of this earnings report all along.

The base case follows the company's own guidance most closely. FY2027 growth at +13%, Data Center at -17%, Cloud at +25.5%, non-GAAP operating margin at 25% — all achieved per guidance. FY2028 sees a modest re-acceleration to perhaps 15 to 17%, not the high-teens recovery some optimists envision. SBC falls but stays above 15%, keeping GAAP operating margin in the mid-single digits. AI strategy improves product stickiness without becoming a standalone revenue engine at meaningful scale in the near term. In this scenario, Atlassian is "a good business that can't quite justify a premium valuation on current growth alone" — and the market will spend FY2027 recalibrating between the Q4 FY2026 peak and whatever the actual annual trajectory turns out to be. I think this base case is the most honest read of the guidance, largely because the company's own disclosure has been unusually candid — explicitly acknowledging the pull-forward, not concealing the -17% Data Center outlook, and flagging the margin compression in the same document where the market found its "margin story."

Over the next two to three years, three variables will determine this stock's direction more than anything else. Whether Cloud's organic growth rate holds above 20% after the DC-to-Cloud migration is substantially complete — this is the hardest variable to forecast with confidence. Whether SBC actually falls 3 to 4 points per year, meaningfully narrowing the GAAP-to-non-GAAP gap in a way that expands the institutional investor base. And whether Rovo and MCP produce measurable monetizable revenue rather than just engagement metrics that look impressive in shareholder letters. If two or more of these confirm positively, the current valuation has a credible path to justification. If all three remain uncertain, "excessive premium for a margin story that isn't materializing" is a hard critique to refute.

FY2026's Rule of 40: 26 (growth) plus 30 (non-GAAP operating margin) equals 56 — a healthy and widely respected score. On FY2027 guidance: 13 plus 25 equals 38, which dips below the 40 threshold the software industry commonly uses as a benchmark. The fall from 56 to 38 is directionally significant even if Rule of 40 is just one frame among many. If FY2028 re-acceleration brings growth to 17% while non-GAAP operating margin holds at 25%, the score recovers to 42 — back above 40. That arithmetic is probably what the market is implicitly pricing right now. FY2027 Q1 results and their implications for whether H2 will be as challenging as the base effect math suggests will be the first real data point in that story.

The metrics worth monitoring every quarter are clear. Cloud revenue growth relative to 25% is the demand health barometer. RPO growth sustaining above 40% is the forward visibility check. Accounts receivable days improving is the cash quality signal. SBC as a percentage of revenue tracking toward 19% is the profitability normalization proof. GAAP operating margin at or above 4.5% is the credibility test for the guidance. Rovo paid conversion rates and any disclosure on MCP-driven incremental revenue are the AI monetization scorecard. Most critically: whether Cannon-Brookes' intention to enter a trading plan results in actual Form 4 purchase disclosures after the cooling-off period — because that transforms an announcement into executed conviction, and it will tell you something important about what the company's founder genuinely believes about the next twelve months.

Sources / References

Related Perspectives

Economy

The Money Wasn't From Selling Hard Drives — The Real Story Behind WDC's Record EPS

Western Digital's Q4 FY2026 results delivered revenue of $3,747M (+44% Y/Y), a record non-GAAP gross margin of 54.4%, and non-GAAP EPS of $3.56 (+109%), beating market consensus on every metric. However, the headline FY26 GAAP EPS of $24.28 conceals a critical structural detail: of the $9,424M in GAAP net income, $6,498M represents non-cash fair value gains on WDC's retained SanDisk stake — earnings entirely unrelated to shipping hard drives. The stock's approximately 11% post-earnings drop traced directly to Q1 FY27 gross margin guidance of 55–56%, which fell short of the elevated industry benchmark set by competitor Seagate. Beneath that guidance gap lies an approximately one-year technology timing difference — Seagate's 44TB HAMR drives are already shipping at volume to hyperscalers, while WDC's HAMR shipment target remains H1 2027. Whether WDC's deliberate choice to delay HAMR while maximizing ePMR UltraSMR margins is a rational capital allocation strategy or a costly market share concession to Seagate is the defining investment question for this stock.

Economy

Uber Is Getting Korea's Top Food Delivery App Because They Lost There — The Most Paradoxical Part of the Delivery Hero Deal

Uber's voluntary public tender offer for Delivery Hero SE has opened a clear path for Baemin (Baedal Minjok) to come under Uber's umbrella, in a deal valued at €41.50 per share and approximately $14.8 billion in fully diluted equity value. South Korea was explicitly listed among the 50 markets Uber is keeping directly — not among the 14 markets being carved out and sold to SSW Partners — because Uber Eats voluntarily exited Korea in October 2019, leaving zero horizontal overlap between the two companies in the Korean delivery market. The same horizontal-combination logic that forced the Korea Fair Trade Commission (KFTC) to require Yogiyo's divestiture in 2020 simply does not apply here, while new regulatory questions around membership bundling and data integration are now coming to the foreground. Uber executed this roughly €14 billion committed bridge at the precise moment its trailing twelve-month free cash flow crossed $10 billion for the first time in company history, pledging to maintain an investment-grade credit rating and keep gross leverage below 2x. The deal's structural logic rests on a cross-platform multiplier effect — users who use both mobility and delivery spend approximately 3x more than single-service users — and the combined entity would span 99 markets with $236 billion in 2025 pro-forma gross bookings. The KFTC's merger review, expected to focus on membership bundling and data combination rather than traditional horizontal overlap, will be the decisive variable determining how deeply Uber and Baemin can integrate in Korea.

Economy

IonQ Revenue Jumped 287% — But the Losses Are 23x That. What's Really Going On?

IonQ's Q2 2026 revenue reached $80.05 million, a 287% year-over-year increase that marked five consecutive quarters of record-breaking results. In the same period, however, net loss hit $1.868 billion — roughly 23.3 times the quarter's revenue — with $1.649 billion of that stemming from non-cash fair value changes on warrant liabilities. Gross margin collapsed from 59.8% to 24.9% year-over-year, and stock-based compensation of $142 million exceeded the quarter's total revenue, revealing a cost structure that demands scrutiny well beyond the growth headline. The $1.8 billion SkyWater Technology acquisition declared IonQ the quantum industry's first vertically integrated manufacturer, but post-acquisition cash fell to roughly $2 billion while first-half operating cash burn reached $255 million. FY2026 revenue guidance was raised to $280–290 million, yet SkyWater's contribution is explicitly excluded from that figure, and warrant liabilities of $3.052 billion now exceed the company's cash and investment holdings of $2.959 billion. Weighted-average share count surged 46.5% year-over-year and accumulated deficit nearly doubled in just six months, widening the gap between IonQ's explosive growth narrative and its financial reality in ways that serious investors cannot afford to overlook.

Economy

The More You Distrust AI, the Better AI Companies Do — The Palantir Q2 Paradox

Palantir Technologies' Q2 2026 results delivered a stunning reversal of market expectations, posting $1.935B in total revenue — a 93% year-over-year growth rate that is extraordinarily rare for a company at this market capitalization scale. U.S. commercial revenue surged 149% to $764M while adjusted operating margins held firm at 62%, producing a Rule of 40 score of 155% that effectively rewrites the software industry's assumed growth-profitability tradeoff. The structural engine behind this acceleration is what the company calls "sovereign AI" — a categorical demand from governments and enterprises that refuse to surrender control of their most sensitive data to public cloud AI platforms. What makes Palantir's position particularly striking is the paradoxical competitive dynamic at its core: the more powerful and capable large AI platforms become, the more anxious institutions grow about handing over classified, proprietary, or competitively vital data — and the more indispensable Palantir's air-gapped AI infrastructure becomes. The stock surged 29% on the trading day following the earnings release yet remains more than 20% below its 52-week high of $207.52, signaling that market skepticism about the long-term sustainability of this growth trajectory persists even as the underlying results are undeniably exceptional.

Economy

Eli Lilly Posted $23B in Revenue. So Why Did the Stock Fall? The Answer Is $3.03.

Eli Lilly (NYSE: LLY) delivered Q2 2026 revenue of $22,974M — a 48% year-over-year increase — while non-GAAP EPS rose 33% to $8.38 and the company raised its full-year revenue guidance to $85.0B–$87.0B, results that by any conventional measure should have sent shares higher. Instead, LLY fell on the day of the announcement, and the explanation lives inside a single accounting line: $3.03 per share in acquired in-process research and development (IPR&D) expenses, representing $2.8B charged from the acquisitions of Orna Therapeutics, Ajax Therapeutics, Kelonia, and Centessa. This charge more than offset management's $2.78 midpoint raise to underlying non-GAAP EPS guidance, producing a paradox where the fundamental business outlook improved yet the final 2026 EPS guidance range settled lower at $35.50–$36.50. Global volumes surged 60% but net realized prices fell 13% globally, with international markets absorbing a 36% price collapse driven primarily by Mounjaro's entry into China's National Reimbursement Drug List — a mechanism distinct from a traditional price war and potentially exportable to other large markets. The Mounjaro-Zepbound duo generated roughly $14.87B in combined quarterly revenue — approximately 65% of total sales — creating a concentration risk that compounds the pricing concern. Novo Nordisk shares also fell roughly 5% on the same day the Danish drugmaker reported near-stagnant full-year guidance of 0% to minus 6%, suggesting the market is repricing the GLP-1 category as a whole rather than any single company's quarter. Retatrutide's planned Q1 2027 BLA submission across three indications and the additional $4.5B Indiana manufacturing commitment are the pivotal variables that will ultimately determine whether Lilly's aggressive invest-while-growing model justifies the premium it commands.

SimNabuleo AI

AI Riffs on the World — AI perspectives at your fingertips

simcreatio [email protected]

Content on this site is based on AI analysis and is reviewed and processed by people, though some inaccuracies may occur.

© 2026 simcreatio(심크리티오), JAEKYEONG SIM(심재경)

enko